Published in Hepatology on September 01, 1997
Liver enzyme alteration: a guide for clinicians. CMAJ (2005) 3.42
Drug-induced autoimmune-like hepatitis. Dig Dis Sci (2011) 2.86
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology (2010) 2.30
Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology (2010) 2.28
Practical guidelines for diagnosis and early management of drug-induced liver injury. World J Gastroenterol (2008) 1.69
Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury. Hepatology (2008) 1.53
RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci (2015) 1.45
The natural history of histologically proved drug induced liver disease. Gut (1999) 1.43
Accuracy of hepatic adverse drug reaction reporting in one English health region. BMJ (1999) 1.31
Drug-Induced Liver Injury: Twenty Five Cases of Acute Hepatitis Following Ingestion of Polygonum multiflorum Thunb. Gut Liver (2011) 1.19
Drug-induced liver injury: is it somehow foreseeable? World J Gastroenterol (2009) 1.18
Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol (2008) 1.18
Acute liver failure due to amoxicillin and amoxicillin/clavulanate. Dig Dis Sci (2005) 1.12
Drug-induced liver injury: present and future. Clin Mol Hepatol (2012) 1.06
Persistent hypertransaminasemia in asymptomatic children: a stepwise approach. World J Gastroenterol (2013) 1.06
Liver Injury from Herbal, Dietary, and Weight Loss Supplements: a Review. J Clin Transl Hepatol (2015) 1.03
Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists. World J Gastroenterol (2007) 1.03
Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug-Induced Liver Injury Network (DILIN). Liver Int (2014) 1.02
An Update on Drug-induced Liver Injury. J Clin Exp Hepatol (2012) 1.01
Toxic hepatitis in occupational exposure to solvents. World J Gastroenterol (2012) 0.98
Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis? J Clin Transl Hepatol (2013) 0.96
Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis. J Gastroenterol (2008) 0.96
Acute liver failure associated with levetiracetam and lacosamide combination treatment for unspecified epileptic disorder. Case Rep Emerg Med (2013) 0.95
Causality assessment for suspected DILI during clinical phases of drug development. Drug Saf (2014) 0.91
Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods. World J Gastroenterol (2013) 0.87
Occupational hepatic disorders in Korea. J Korean Med Sci (2010) 0.87
Acute hepatitis induced by bupropion. Dig Dis Sci (2000) 0.87
A case of prolonged cholestatic hepatitis induced by azithromycin in a young woman. Case Reports Hepatol (2012) 0.86
N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review protocol. Syst Rev (2015) 0.86
Clinicopathological features of severe and fulminant forms of autoimmune hepatitis. J Gastroenterol (2010) 0.86
Trastuzumab-induced hepatotoxicity: a case report. Breast Care (Basel) (2013) 0.85
Drug-Induced Liver Injury Associated with Noni (Morinda citrifolia) Juice and Phenobarbital. Case Rep Gastroenterol (2013) 0.85
Drug-Induced Liver Injury: Pattern Recognition and Future Directions. Gut Liver (2016) 0.84
Detective work in drug-induced liver injury: sometimes it is all about interviewing the right witness. Clin Gastroenterol Hepatol (2010) 0.84
Jaundice in African-American and Hispanic patients with AIDS. J Natl Med Assoc (2007) 0.84
Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review. Int J Gen Med (2013) 0.83
The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis. Clin Mol Hepatol (2012) 0.83
A Case of Drug-Induced Hepatitis due to Lenalidomide. Case Rep Gastroenterol (2011) 0.83
An evaluation of hepatotoxicity in breast cancer patients receiving injection Doxorubicin. Ann Med Health Sci Res (2014) 0.83
A fatal case of bupropion (Zyban) hepatotoxicity with autoimmune features: Case report. J Med Case Rep (2007) 0.83
Drug-induced liver injury: the dawn of biomarkers? F1000Prime Rep (2015) 0.82
Efficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis. Dig Dis Sci (2011) 0.82
Hepatotoxicity in patients with cirrhosis, an often unrecognized problem: lessons from a fatal case related to amoxicillin/clavulanic acid. Dig Dis Sci (2001) 0.82
Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States. Int J Mol Sci (2016) 0.81
An Update on Treatment of Drug-Induced Liver Injury. J Clin Transl Hepatol (2014) 0.81
Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf (2016) 0.80
Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease. Biomed Res Int (2015) 0.80
Khat (Catha Edulis) as a possible cause of autoimmune hepatitis. World J Hepatol (2014) 0.80
Grand rounds: an outbreak of toxic hepatitis among industrial waste disposal workers. Environ Health Perspect (2007) 0.79
Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation. World J Gastroenterol (2009) 0.79
N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review. Br J Clin Pharmacol (2016) 0.79
Chinese Herbal Medicine-induced Liver Injury. J Clin Transl Hepatol (2014) 0.79
Case report: hexachloroethane smoke inhalation: a rare cause of severe hepatic injuries. Environ Health Perspect (2006) 0.79
Acute liver failure associated with occupational exposure to tetrachloroethylene. J Korean Med Sci (2010) 0.78
DILI: New Insights into Diagnosis and Management. Curr Hepat Rep (2013) 0.78
Clinicopathological correlates in HIV seropositive tuberculosis cases presenting with jaundice after initiating antiretroviral therapy with a structured review of the literature. BMC Infect Dis (2012) 0.78
Polymorphisms in CTLA4 influence incidence of drug-induced liver injury after renal transplantation in Chinese recipients. PLoS One (2012) 0.78
Clopidogrel-induced liver failure. JRSM Short Rep (2011) 0.78
Impact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Chinese pediatric patients. PLoS One (2014) 0.77
Recurrent Acute Liver Failure Because of Acute Hepatitis Induced by Organic Solvents: A Case Report. Medicine (Baltimore) (2016) 0.77
Drug-induced liver injury caused by adalimumab: a case report and review of the bibliography. Case Reports Hepatol (2013) 0.77
[Morphology of drug induced liver damage]. Pathologe (2006) 0.76
Herbal and dietary supplement-induced liver injury. Gastroenterol Hepatol (N Y) (2011) 0.76
Case report and cohort analysis of drug-induced liver injury associated with daptomycin. Antimicrob Agents Chemother (2014) 0.76
Drug-induced Liver Injury. US Gastroenterol Hepatol Rev (2010) 0.76
Acute Liver Failure Following One Year of Daily Consumption of a Sugar-Free Energy Drink. ACG Case Rep J (2014) 0.76
Anakinra Hepatotoxicity in a Patient With Adult-Onset Still's Disease. ACG Case Rep J (2015) 0.75
Research Advances on Hepatotoxicity of Herbal Medicines in China. Biomed Res Int (2016) 0.75
Repeated exposure to modern volatile anaesthetics may cause chronic hepatitis as well as acute liver injury. BMJ Case Rep (2012) 0.75
Liver Function Test Abnormalities in Depressed Patients Treated with Antidepressants: A Real-World Systematic Observational Study in Psychiatric Settings. PLoS One (2016) 0.75
Acute liver injury in two workers exposed to chloroform in cleanrooms: a case report. Ann Occup Environ Med (2014) 0.75
Acute cholestatic hepatitis caused by amoxicillin/clavulanate. World J Gastroenterol (2013) 0.75
Analysis of liver function test abnormalities in kidney transplant recipients: 7 year experience. Pak J Med Sci (2017) 0.75
A Rare Case of Paclitaxel and/or Trastuzumab Induced Acute Hepatic Necrosis. Case Rep Oncol Med (2015) 0.75
Hepatotoxicity induced by trimethoprim-sulfamethoxazole in a child with cystic fibrosis. J Pediatr Pharmacol Ther (2014) 0.75
Severe cholestatic hepatitis induced by pyritinol. BMJ (2004) 0.75
Dimethylacetamide-induced occupational toxic hepatitis with a short term recurrence: a rare case report. J Thorac Dis (2016) 0.75
Tolcapone-related fulminant hepatitis: electron microscopy shows mitochondrial alterations. Dig Dis Sci (2000) 0.75
Severe liver injury due to a homemade flower pollen preparation in a patient with high CYP3A enzyme activity: a case report. Eur J Clin Pharmacol (2016) 0.75
Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM. Drug Saf (2017) 0.75
Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury. Gut (1997) 2.35
Alteration in T lymphocyte subpopulations in inflammatory bowel disease. Clin Exp Immunol (1980) 1.13
Jaundice associated with naproxen. Postgrad Med J (1980) 1.05
Spontaneous suppressor cell function in inflammatory bowel disease. Dig Dis Sci (1981) 1.04
Comparison of the frequency of interleukin (IL)-2-, interferon-gamma-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes. J Infect Dis (2001) 1.03
Lymphocyte reactivity to ex-vivo drug antigens in drug-induced hepatitis. J Hepatol (1994) 1.02
Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome. Clin Exp Immunol (1982) 1.00
Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection. J Immunol (1999) 0.93
Relationship between T cell subpopulations and the mitogen responsiveness and suppressor cell function of peripheral blood mononuclear cells in normal individuals. Clin Exp Immunol (1980) 0.93
Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicity. AIDS (2000) 0.92
Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery. Clin Exp Immunol (1999) 0.91
T-helper cross reactivity to viral recombinant proteins in HIV-2-infected patients. AIDS (1993) 0.88
Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness. J Clin Lab Immunol (1983) 0.86
T-helper reactivity to simian immunodeficiency virus gag synthetic peptides in human immunodeficiency virus type 2 infected individuals. J Med Virol (1995) 0.86
Analysis of lymphocyte cell death and apoptosis in HIV-2-infected patients. Clin Exp Immunol (1994) 0.85
Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitization. Arch Intern Med (1987) 0.85
Loss of CD45RA and gain of CD45RO after in vitro activation of lymphocytes from HIV-infected patients. Immunology (1991) 0.85
Single-cell analysis of lymphokine imbalance in asymptomatic HIV-1 infection: evidence for a major alteration within the CD8+ T cell subset. Clin Exp Immunol (1998) 0.82
Drug-induced hepatitis and lymphocyte transformation test in presence of prostaglandin inhibitor. Lancet (1986) 0.82
Hypersensitivity immune reaction as a mechanism for dilevalol-associated hepatitis. Ann Pharmacother (1992) 0.80
Agranulocytosis and liver damage associated with pyrazinobutazone with evidence for an immunological mechanism. J Rheumatol (1989) 0.80
Disturbed immunoregulatory properties of the neuropeptide substance P on lymphocyte proliferation in HIV infection. Clin Exp Immunol (1994) 0.80
Inhibition of lymphocyte proliferation induced in vitro by microbial antigens in HIV-infected subjects. J Med Virol (1991) 0.79
Fatal hepatitis associated with ranitidine. Am J Gastroenterol (2000) 0.78
Distinct alterations in the distribution of CD45RO+ T-cell subsets in HIV-2 compared with HIV-1 infection. AIDS (1994) 0.78
Remission of precapillary pulmonary hypertension in systemic lupus erythematosus. J R Soc Med (2001) 0.78
The short lived suppressor cell assay and its relationship with mitogen responsiveness in normal individuals. J Clin Lab Immunol (1981) 0.78
Modifications of the lymphocyte transformation test in a case of drug-induced cholestatic hepatitis. Diagn Immunol (1985) 0.77
Effects of the neuropeptide, substance P, on lymphocyte proliferation in rheumatoid arthritis. J Int Med Res (1997) 0.77
Bulk cytokine production versus frequency of cytokine-producing cells in HIV1 infection before and during HAART. Clin Immunol (2000) 0.77
Immunological investigation in hepatic drug reactions. Clin Exp Allergy (1998) 0.77
HIV infection and intestinal pseudo-obstruction. AIDS (1990) 0.76
Effects of substance P on human T cell function and the modulatory role of peptidase inhibitors. Int J Clin Lab Res (1997) 0.76
Takayasu's disease presenting as a nephrotic syndrome due to amyloidosis. Postgrad Med J (1993) 0.75
Studies on the suppression of a one-way mixed lymphocyte reaction by mitomycin-C treated responder cells. Immunology (1980) 0.75
[Headaches, otalgia and peripheral facial palsy as a form of presentation of neurosyphilis]. Rev Neurol (2005) 0.75
Absence of HTLV-III/LAV antibodies in ex-residents from Angola and Mozambique returning to Portugal before 1979. Acta Med Port (1986) 0.75
Immunologic mechanism in sulphasalazine-induced agranulocytosis. Acta Haematol (1990) 0.75
Centrocytic lymphoma presenting as a subphrenic abscess and a solitary liver nodule. Hepatogastroenterology (1997) 0.75
[Visceral leishmaniasis and HIV infection: the diagnostic and therapeutic problems]. Acta Med Port (1993) 0.75
[Collagenous colitis: clinical and histologic improvement after sulfasalazine and topical betamethasone]. Acta Med Port (1992) 0.75
[Cytomegalovirus-induced colitis in HIV infection. Considerations on its diagnosis, treatment and complications]. Acta Med Port (1995) 0.75
Peripheral T-cell phenotypes in chronic active hepatitis B. Correlation with serum hepatitis B virus (HBV) markers and clinical features. J Hepatol (1986) 0.75
[The use of serological tests for detecting HIV infection in general clinical consultations and hospital consultations]. Acta Med Port (1995) 0.75
Autologous rosette-forming T cells and their relationship to OKT4+ and OKT8+ cells in chronic HBV infection. J Clin Lab Immunol (1986) 0.75
[Autoimmune hemolytic anemia and ulcerative colitis]. Acta Med Port (1995) 0.75
Lymphocyte proliferative response to drugs: Analysis of the value of a 24-well lymphocyte culture system. Toxicol In Vitro (1994) 0.75
[Prevalence of HIV1 and HIV2 infection in women living in an area of Lisboa City]. Acta Med Port (1991) 0.75
Halothane aggravation of chronic liver disease. Acta Med Port (1984) 0.75
Attenuated vaccines for AIDS. Lancet (1995) 0.75
Studies on the suppression of lymphocyte proliferation by concanavalin-A activated mononuclear cells in normal individuals. Acta Med Port (1984) 0.75
Severe osteomalacia associated with renal tubular acidosis in Crohn's disease. Dig Dis Sci (1986) 0.75